ESR1 and breast carcinoma: However, another study demonstrated that sorcin was only involved in the development of low-level paclitaxel resistance when full-length sorcin cDNA was transfected into MCF-7 human breast cancer cells, which are estrogen receptor-positive, and MDA-MB435S (parental MCF-7) cells (14).